Related by context. All words. (Click for frequent words.) 78 Nitazoxanide 76 Dasatinib 75 Pafuramidine 75 Meets Primary Endpoint 75 Pazopanib 75 Hsp# Inhibitor 74 IMiDs ® 74 Anidulafungin 74 Investigational Treatment 74 Pegloticase 74 selective orally bioavailable 74 Initiates Clinical 74 Civacir 74 PDE4 inhibitor 74 Sapacitabine 73 Romidepsin 73 non nucleoside inhibitor 73 Fluconazole 73 IMiDs R 73 proteasome inhibitor 73 nucleoside analog 73 Initiate Phase 73 oral prodrug 73 intranasal formulation 73 Aliskiren 73 Voreloxin 73 Mipomersen 73 Aflibercept 73 Omacetaxine 73 Granulocyte Colony Stimulating Factor 72 Epratuzumab 72 Talabostat 72 orally bioavailable 72 Initiates Phase II 72 Noxafil 72 PEGylated Fab fragment 72 Ganciclovir 72 Initiates Enrollment 72 Vicriviroc 72 Initiates Phase III 72 SPRYCEL ® 72 Investigational Compound 72 Mitoxantrone 72 Initiate Clinical Trial 72 Irinotecan 72 inhalation powder 72 Bosutinib 72 Recombinant Human 72 polymerase inhibitor 72 vinca alkaloid 72 Drug Candidate 72 Vidaza azacitidine 72 Initiates Clinical Trial 72 novel immunomodulatory 72 Eltrombopag 72 humanized monoclonal 72 Ustekinumab 72 Tezampanel 72 MAGE A3 ASCI 72 HCV RNA polymerase 72 Peginterferon alfa 2b 71 neuraminidase inhibitor 71 Completes Patient Enrollment 71 Darusentan 71 liposomal formulation 71 Cethromycin 71 Darunavir 71 Boceprevir 71 TNF Tumor Necrosis Factor 71 YONDELIS 71 Fluticasone 71 targeted radiotherapeutic 71 histone deacetylase HDAC inhibitor 71 Moxifloxacin 71 Pharmacokinetics PK 71 investigational humanized monoclonal antibody 71 adalimumab Humira 71 IMiDs ® compound 71 Aurora Kinase 71 Atripla combines 71 Pertuzumab 71 Phase 2b Clinical Trial 71 selective antagonist 71 ZOLINZA 71 receptor tyrosine kinase inhibitor 71 Aptivus ® 71 corticosteroid dexamethasone 71 Files IND 71 thalidomide Thalomid 71 Receives Orphan Drug Designation 71 FOR FURTHER INFORMATION ABOUT 71 JAK inhibitor 71 Darinaparsin 71 Antiangiogenic 71 alefacept 71 Aviptadil 71 Arimoclomol 71 mertansine 71 Sustiva efavirenz 71 Azacitidine 71 Cancidas 71 Dapagliflozin 71 Vidofludimus 71 Ridaforolimus 71 Entry Inhibitor 71 Transdermal Patch 71 Nilotinib 71 Archexin 71 Blinatumomab 71 Antitumor Activity 71 Doripenem 71 Lenalidomide 71 sodium glucose cotransporter 71 Bafetinib 70 Fast Track Status 70 ADP receptor antagonist 70 PNP inhibitor 70 Achieves Primary Endpoint 70 Bremelanotide 70 Daclizumab 70 leukotriene receptor antagonist 70 Pulmonary Arterial Hypertension 70 Granted Orphan Drug 70 Demonstrates Potent 70 rilonacept 70 Deforolimus 70 Pivotal Phase III 70 HQK 70 Temsirolimus 70 erlotinib Tarceva ® 70 Presents Preclinical Data 70 Gleevec resistant 70 peripherally acting 70 Phase IIb Trial 70 Protease Inhibitor 70 metaglidasen 70 orally administered inhibitor 70 Vfend 70 Velcade bortezomib 70 Vaccine Adjuvant 70 Dalbavancin 70 Clindamycin 70 JAK Inhibitor 70 Factor VIIa 70 Ecallantide 70 dihydrochloride 70 Azathioprine 70 Submits NDA 70 Melphalan 70 Novel Antibiotic 70 Previously Treated 70 Levofloxacin 70 Anti Tumor 70 Itraconazole 70 Anavex #-# 70 Bazedoxifene 70 Alemtuzumab 70 developing Zerenex ferric 70 docetaxel Taxotere ® 70 Zorbtive TM 70 Xeloda ® 70 nucleoside analogue 70 Fondaparinux 70 Laquinimod 70 Personalized Immunotherapy 70 MTP inhibitor 70 Daptomycin 70 Phase 2b Trial 70 Indomethacin 70 Romiplostim 70 Etravirine 70 Gemzar gemcitabine 70 Cytarabine 70 Safinamide 70 gets USFDA nod 70 Thiovir 70 Peginterferon 70 MOVIPREP R 70 ATG Fresenius S 70 selective modulator 70 generation purine nucleoside 70 Fingolimod 70 Successfully Completes Phase 70 meropenem 70 Immunotherapeutic 70 beta 1a 70 Kinase Inhibitor 70 RNAi Therapeutic 70 dasatinib Sprycel ® 70 PEGylated anti 70 Glufosfamide 70 ® lenalidomide 70 Piperacillin 70 Presents Preclinical 70 Prolongs Survival 70 Gleevec imatinib mesylate 70 CYT# potent vascular disrupting 70 MEK inhibitor 70 FDA Accepts 70 IND Application 70 Panzem R 70 Elesclomol 70 Glatiramer Acetate 70 IV Busulfex 70 Clevudine 70 Vidaza R 70 Mg Usa 70 AEG# 70 pan HDAC inhibitor 70 oral renin inhibitor 70 Tarceva TM 69 octreotide acetate 69 microtubule inhibitor 69 itraconazole Sporanox 69 Oral Spray 69 Clofarabine 69 CCR5 antagonist 69 HDAC Inhibitor 69 Interferon Beta 69 reslizumab 69 IMiDs 69 lipoglycopeptide 69 Orally Active 69 forodesine 69 TLR9 agonist 69 anticoagulant reversing agent 69 Tyrosine Kinase Inhibitor 69 Known generically 69 thiazolides 69 Tumor Necrosis Factor 69 tenofovir Viread 69 Orally administered 69 Genentech Rituxan 69 cetuximab Erbitux R 69 hypereosinophilic syndrome 69 PRN FDA Approves 69 Pathway Inhibitor 69 Golimumab 69 indinavir Crixivan 69 BAL# [002] 69 Belimumab 69 Eraxis 69 Elvitegravir 69 topical gel formulation 69 2 methoxyestradiol 69 BCR ABL inhibitors 69 antibody MAb 69 5 HT3 antagonist 69 GW# [003] 69 Fc fusion protein 69 Tesetaxel 69 Epidermal Growth Factor Receptor 69 Anticancer Agent 69 acyclovir Lauriad R 69 evaluating tivozanib 69 Liprotamase 69 Medoxomil 69 Interferon alfa 69 Saquinavir 69 Nucleoside 69 novel oral anticoagulant 69 methylnaltrexone bromide 69 Phase III Clinical Trial 69 Benazepril 69 Sumatriptan Succinate 69 systemic fungal infections 69 treat chronic sinusitis 69 Leukine ® 69 nucleoside reverse transcriptase inhibitor 69 imatinib Gleevec ® 69 Cloretazine 69 Receptor Agonist 69 Adalimumab 69 JAK2 Inhibitor 69 Decitabine 69 Onconase 69 Pimavanserin 69 Denufosol 69 SUSTENNA TM 69 oral antiviral 69 R#/MEM # 69 mGluR5 NAM 69 CDP# 69 Hepatitis C Virus 69 Friedreich Ataxia FRDA 69 Bucindolol 69 Crizotinib 69 Diabetic Neuropathy 69 Arcalyst 69 Erlotinib 69 Tyrima 69 immunomodulator 69 Bortezomib 69 Xanafide 69 Trial Evaluating 69 Enzyme Replacement Therapy 69 Nanoemulsion 69 Lamivudine 69 rxRNA 69 Lubiprostone 69 RhuDex ® 69 Imatinib mesylate 69 Oxaliplatin 69 Demonstrates Positive 69 mesylate 69 xanthine oxidase inhibitor 69 Tigecycline 69 regorafenib 69 Teriflunomide 69 RECOTHROM R 69 PDE# 69 sorafenib tablets 69 MEK inhibitors 69 Ambrisentan 69 Lamictal ODT 69 Ciclesonide 69 Anthracycline 69 highly selective inhibitor 69 proteasome inhibitors 69 Zolinza 69 PEGylated interferon 69 Presents Positive 69 Macrolide 69 Well Tolerated 69 Abacavir 69 gastrointestinal stromal tumors GIST 69 echinocandin 69 Methylnaltrexone 69 renin inhibitor 69 cidofovir 69 Naive Patients 69 Bendamustine 69 Bezielle 69 Announces Tentative Approval 69 Pemetrexed 69 Levoleucovorin 69 Filgrastim 69 sorafenib Nexavar 69 NS#/#A protease 69 Lacosamide 69 Carfilzomib 69 Pradefovir 69 Aztreonam 69 Interferon beta 69 Psoriasis Drug 69 Vandetanib 69 Ixabepilone 69 Muraglitazar 69 Chemokine Receptor 69 Bicifadine 69 LymphoStat B TM 69 MKC# MT 69 Cetrorelix 69 Submits IND 68 torezolid 68 Ceftaroline 68 Degarelix 68 Progressive Multifocal Leukoencephalopathy 68 DP VPA 68 Tacrolimus 68 Kuvan sapropterin dihydrochloride 68 Cyclosporin 68 Fixed Dose Combination 68 Remicade infliximab 68 Dacogen decitabine 68 Levetiracetam 68 Tesamorelin 68 Silodosin 68 Traficet EN 68 IMA# 68 daptomycin 68 Pregabalin 68 acetonide FA 68 Rilonacept 68 nucleoside analogs 68 Cytotoxic 68 long acting muscarinic 68 Rotavirus Vaccine 68 Galantamine 68 dasatinib Sprycel 68 panitumumab Vectibix 68 volociximab 68 MEK Inhibitor 68 Patients Treated With 68 Sudhir Agrawal D.Phil 68 Argatroban 68 epothilones 68 Aganocide 68 Prostate Cancer Vaccine 68 AVONEX ® 68 Tanespimycin 68 Novel Oral 68 Simulect 68 Carbamazepine 68 Monoclonal Antibody 68 Efficacy Trial 68 targeted antifolate 68 Mg Uk 68 etanercept Enbrel 68 XL# XL# 68 Inhalation Powder 68 developing Bicifadine serotonin 68 Tasimelteon 68 interferon gamma 1b 68 DORIBAX 68 benzimidazole 68 LymphoStat B belimumab 68 HCD# [002] 68 HuMax CD4 68 Prodrug 68 metformin hydrochloride 68 Interferon beta 1b 68 VitiGam TM 68 Gefitinib 68 Pegylated 68 Varespladib 68 selective kinase inhibitor 68 Myelodysplastic Syndrome MDS 68 Perifosine 68 NXL# 68 Vitrasert R 68 humanised monoclonal antibody 68 immunomodulatory properties 68 refractory gout 68 Files Investigational 68 Generic Versions 68 topical ocular 68 oropharyngeal candidiasis 68 immune modulating 68 Demonstrates Significant 68 investigational pharmacologically unique 68 Zenpep 68 invasive candidiasis 68 Fludara ® 68 NDA Submission 68 DU #b 68 Raltegravir 68 immunotherapeutic vaccine 68 mTOR inhibitor 68 Febuxostat 68 dihydrofolate reductase 68 orally dosed 68 Trabectedin 68 oral dual endothelin 68 Budesonide 68 Mirapexin 68 Preclinical Data 68 targeting CD# 68 Receives Orphan Drug 68 Drug Shows Promise 68 SUTENT ® 68 Investigational Oral 68 Single Dose 68 omalizumab Xolair 68 Zileuton 68 Formoterol 68 bortezomib Velcade 68 relapsed MM 68 HCV polymerase 68 SinuNase TM 68 HCV Protease Inhibitor 68 Severe Sepsis 68 Belerofon 68 alkylating agent 68 Combination Therapy 68 INTEGRILIN R 68 lomitapide 68 Lung Cancer Drug 68 PRTX 68 tigecycline 68 Alferon N 68 novel emulsion formulation 68 5 HT2A inverse 68 Treatment Naïve 68 miconazole Lauriad ® 68 Cimzia TM 68 Palonosetron 68 Intelence 68 PKC# 68 Generic Version Of 68 Tocilizumab 68 IAP inhibitors 68 Faropenem 68 docetaxel Taxotere R 68 Topotecan 68 levetiracetam Keppra 68 TELINTRA 68 BARACLUDE R 68 Shows Efficacy 68 nucleotide analog 68 Integrase Inhibitor 68 CEQ# 68 Tykerb lapatinib 68 ACHN 68 novel histone deacetylase 68 Omnaris 68 Epothilones 68 Octreotide 68 Eculizumab 68 Dabigatran etexilate 68 Telbivudine 68 telaprevir VX 68 EVIZON TM 68 ceftazidime 68 chimeric monoclonal antibody 68 ergot derivatives 68 prescribed proton pump 68 phase III isavuconazole 68 Liposomal 68 visilizumab 68 selective estrogen receptor modulator 68 Long Term Efficacy 68 ALN HPN 68 FOLOTYN ® 68 abacavir Ziagen 68 Arranon 68 Ropinirole 68 HCV NS3 protease 68 Receives Approvable Letter 68 Vildagliptin 68 HCl Tablets 68 recombinant subunit vaccine 68 DermaVir Patch 68 Elagolix 68 Peginterferon Alfa 2a 68 Pramlintide 68 Systemic Delivery 68 Fenofibrate 68 ritonavir boosted 68 HSP# inhibitor 68 Valsartan 68 SPIRIVA ® 68 SPRIX ® 68 adefovir dipivoxil 68 Inhalation Solution 68 Olaparib 68 Ofatumumab 68 small molecule tyrosine 68 Perindopril 68 nucleotide analogue 68 OHR/AVR# 68 Pivotal Phase 68 Telithromycin 68 Desvenlafaxine 68 Tibotec Therapeutics division 68 GSK# [002] 68 Zeldox 68 Zelapar 68 Monopril 68 investigational oral inhibitor 68 PEG SN# 68 topical ophthalmic 68 FDA APPROVES 68 Fabry Disease 68 HoFH 68 Proquin XR 68 cilengitide 68 Xyfid TM 68 Navelbine ® 68 Radezolid 68 Gout Drug 68 Mylan Receives Approval 68 MKC# MKC# PP 68 topical antifungal 68 Phase IIa Clinical Trial 68 non nucleoside HCV 68 inhibitor PPI 68 Montelukast 68 Phase 2a Trial 68 Generic Version 68 Metronidazole 68 Nipent R 68 INVANZ 68 PGL# 68 Interferon beta 1a 68 Monoclonal antibody 68 Adenoviral 68 mapatumumab 68 Topiramate 68 Rotigotine 68 topical gel containing 67 Begins Dosing 67 ORENCIA R 67 inhaled formulation 67 Bicalutamide 67 teriflunomide 67 Aptamer 67 Panzem 67 Advanced Melanoma 67 Posaconazole 67 Elotuzumab 67 peptibody 67 SAR# [002] 67 Sitagliptin 67 Actemra tocilizumab 67 ANDA Filing 67 virus HCV protease inhibitor 67 Potent Inhibitor 67 Entecavir 67 Pruvel TM 67 STELARA TM 67 protein tyrosine phosphatase 1B 67 Zalypsis 67 cutaneous T 67 protein kinase inhibitor 67 TBC# 67 defensin mimetic antibiotic 67 Paliperidone Palmitate 67 Hycamtin 67 CCR5 inhibitor 67 Levaquin levofloxacin 67 Trandolapril 67 nucleotide analogs 67 AVP #D# 67 Annamycin 67 Investigational Drug 67 miconazole Lauriad R 67 aripiprazole Abilify 67 product candidate Lpathomab 67 Multiple Ascending Dose 67 R Saizen R 67 Iloperidone 67 sertraline Zoloft 67 Paraplatin ® 67 Alfacell proprietary ribonuclease 67 ACE Inhibitors 67 Cinquil 67 Crofelemer 67 Linaclotide 67 hormone LHRH antagonist 67 Nexavar ® 67 Tolvaptan 67 ALN PCS 67 immunotherapeutic agent 67 quinolone 67 Alkeran 67 pegylated 67 Kinoid 67 candidate TNFerade biologic 67 telomerase therapeutic 67 efaproxiral 67 Proleukin 67 soluble tumor necrosis 67 KAPVAY ™ 67 vapreotide acetate 67 Saxagliptin 67 KL4 Surfactant 67 chronic eosinophilic leukemia 67 Respiratory Syncytial Virus RSV 67 fumarate 67 Cefepime 67 Iluvien ® 67 HCl capsules 67 Zegerid OTC 67 investigational protease inhibitor 67 ara C 67 diarrhea predominant irritable 67 canakinumab 67 Gamunex C 67 Phase 2a Clinical Trial 67 Roflumilast 67 Therapeutic Vaccine 67 novel DACH platinum 67 tazobactam 67 neratinib 67 Ramelteon 67 Miconazole 67 Transdermal Delivery 67 Novel Therapeutic 67 esomeprazole Nexium 67 pegylated interferon alpha 67 Copegus ribavirin 67 highly purified pasteurized 67 Diabetic Nephropathy 67 MKC# 67 Initiates Phase 67 GSK '# 67 lapatinib Tykerb 67 Akt inhibitor 67 PrevOnco 67 R sorafenib tablets 67 M# rationally 67 Camptosar ® 67 #mg/#mg 67 novel topoisomerase 67 dopamine partial agonist 67 Bavituximab 67 MGd 67 small molecule Hedgehog 67 myelodysplastic myeloproliferative diseases 67 Lixivaptan 67 FDA Okays 67 Parnate 67 HEPLISAV TM 67 VISICOL R 67 HepaGam B 67 Complicated Skin 67 platelet inhibitor 67 R lenalidomide 67 Extended Release 67 HIV integrase inhibitor 67 Vorinostat 67 brand ciclesonide HFA 67 calcineurin inhibitors 67 Lenocta 67 Initiates Dosing 67 HGS# 67 IL# PE#QQR 67 PSN# [001] 67 Japanese Encephalitis Vaccine 67 Taxane 67 Gemzar ® 67 betamethasone dipropionate 67 pharmacokinetic interactions 67 Etoposide 67 Natalizumab 67 reverse transcriptase inhibitors 67 Rifaximin 67 Indaflex TM 67 HGS ETR2 67 Protease Inhibitors 67 Immunomodulatory 67 XYOTAX TM 67 fluoroquinolone antibiotic 67 AAG geldanamycin analog 67 Oritavancin 67 Amrubicin 67 ketolide antibiotic 67 Atrasentan 67 Allovectin 7 67 Ixempra 67 HCV NS5B polymerase 67 RELOVAIR ™ 67 small molecule glucokinase 67 enzyme inhibitor 67 alfa 2a 67 Seliciclib 67 rituximab Rituxan 67 pleconaril 67 carbapenem 67 Antibacterials 67 insulin sensitizers 67 radezolid 67 INSPIRE Trial Phase III 67 TRO# 67 IAP inhibitor 67 oral salmon calcitonin 67 prostanoid 67 CIMZIA R 67 multi kinase inhibitor 67 Replacement Therapy 67 CDDO Im 67 Gilead Viread 67 JAK2 inhibitor 67 BiovaxID TM 67 Clinical Trial Results 67 APTIVUS 67 topically administered 67 ATL# [002] 67 HuMax EGFr 67 zidovudine AZT 67 Valtrex valacyclovir 67 outlicensed 67 Small Molecule 67 sunitinib Sutent ® 67 Naproxcinod 67 von Willebrand Factor 67 Pegylated Interferon 67 selective A2A adenosine receptor 67 Antitumor 67 Lixisenatide 67 Certolizumab pegol 67 Carbidopa 67 Firazyr 67 ALVESCO R 67 Lanthanum Carbonate 67 HGS ETR1 mapatumumab 67 AKT inhibitor 67 Paliperidone ER 67 Novel Mechanism 67 Phase IIb Clinical Trial 67 amphotericin B 67 basiliximab 67 Present Preclinical Data 67 Valopicitabine 67 Alinia 67 Pivotal Study 67 selective serotonin 2C receptor 67 SCH # 67 Panzem R NCD 67 HCV protease inhibitors 67 Novel Compound 67 Palifosfamide 67 GA GCB 67 Maraviroc 67 Plicera 67 TO AVOID PREGNANCY WHILE 67 Previously Untreated 67 Monotherapy 67 Orphan Status 67 CYP#A# CYP#D# 67 LAB CGRP 67 Squalamine 67 denileukin diftitox 67 Valproic acid 67 Tegaserod 67 Intranasal 67 CCX# 67 Allergic Rhinitis 67 Spiegelmer ® 67 Randomized Phase 67 novel peptide 67 Disease Modifying 67 Tumor Targeting 67 ORENCIA ® 67 Desmopressin 67 cMET 67 Dose Escalation 67 Milestone Payment From 67 CCR5 receptor antagonist 67 Atopic Dermatitis 67 topoisomerase II inhibitor 67 Oral Fingolimod 67 parenterally administered 67 Metastatic Melanoma 67 CCR5 mAb 67 Sym# 67 oral proteasome inhibitor 67 Sevelamer 67 Kepivance 67 Seroquel quetiapine fumarate 67 Interferon alpha 2b 67 Tesmilifene 67 Sodium oxybate 67 nelfinavir Viracept 67 transcriptase inhibitor NNRTI 67 receptor modulators 67 Wellstat 67 long acting bronchodilator 67 nanofiltered plasma derived 67 Receive Milestone Payment 67 therapeutically inactive prodrug 67 synthetic peptide containing 67 HCl Injection 67 Cyclosporine 67 Prodarsan ® 67 Vertex hepatitis C 67 Submits Supplemental 67 reversible inhibitors 67 Nasal Powder 67 somatostatin analogue 67 Bevirimat 67 uric acid lowering 67 efalizumab 67 Emtriva Viread 67 administered concomitantly 67 RNA antagonists 67 UPLYSO 67 inhibit replication 67 Submits Response 67 BENLYSTA ® 67 Nebulized 66 Teva Provides Update 66 Oral Insulin 66 lucinactant 66 Tofacitinib 66 refractory chronic lymphocytic 66 abacavir sulfate lamivudine 66 selective androgen receptor modulator 66 Cholesterol Lowering Drug 66 Icatibant 66 mild vasodilator 66 emtricitabine tenofovir 66 dopamine receptor agonist 66 Oral Mucositis 66 oral beclomethasone dipropionate 66 5 FU leucovorin 66 vinorelbine tartrate 66 immunomodulators 66 HuLuc# 66 norepinephrine reuptake inhibitor 66 Albugon 66 Therapeutic Competitors Companies 66 Antidepressant Drug 66 Campath ® 66 icatibant 66 Launches Generic Version 66 Receives Fast Track 66 5 HT6 receptor 66 serotonin norepinephrine reuptake inhibitor 66 ganciclovir 66 successfully commercialize Iluvien 66 RiVax 66 ACTEMRA TM 66 generation cephalosporin antibiotic 66 Capecitabine 66 Vidaza ® 66 HFA MDI 66 antiarrhythmic agent 66 Mycophenolate Mofetil 66 Frova ® 66 Roche Actemra 66 thymalfasin 66 BioSante Pharmaceuticals Announces 66 COPEGUS R 66 Antithrombin 66 Pirfenidone 66 BUPHENYL R 66 sulindac 66 Pancreas Cancer Vaccine 66 Hepatitis C Virus HCV 66 Phase #b/#a clinical 66 Inactivated 66 Interferon alpha 66 Anti VEGF 66 Gemcitabine 66 RhuDex 66 Receives Positive Opinion 66 Copegus ® 66 Lupus Drug 66 VEGF inhibitors 66 Perforomist ™ Inhalation Solution 66 Respiratory Virus 66 Angiotensin Converting Enzyme 66 broad spectrum cephalosporin 66 BARACLUDE ® 66 small molecule thrombopoietin 66 investigational integrase inhibitor 66 CCR9 antagonist 66 integrase inhibitor 66 Familial Adenomatous Polyposis FAP 66 Zarnestra 66 thiazolidinedione TZD 66 CERVARIX 66 Zysolin TM 66 Combination REOLYSIN R 66 Riluzole 66 SNT MC# 66 Cardiotoxicity 66 Prodarsan R 66 SPL# Gel vaginal microbicide 66 SinuNase 66 somatostatin analogues 66 mycophenolic acid 66 Tamibarotene 66 Dual Opioid TM 66 immune modulators 66 Gonal f ® 66 DermaVir 66 Humanized Anti 66 First Patient Dosed 66 Phase III Pivotal 66 Rifampicin 66 Thrombin 66 Hospital Acquired Pneumonia 66 immune modulator 66 Aurograb 66 Sporanox 66 adenosine A2A 66 Demonstrated Significant 66 SERMs 66 Bevacizumab 66 Hepatocellular Carcinoma 66 eosinophilic asthma 66 anti secretory 66 oral nucleoside analogue 66 Adjuvant Treatment 66 levocetirizine 66 Unresectable 66 recurrent glioblastoma multiforme 66 Chronic Hepatitis C 66 Iluvien TM 66 FDA Approvals 66 HMG CoA reductase inhibitors 66 Teriparatide 66 Fodosine 66 Isavuconazole 66 Lopinavir 66 novel VDA molecule 66 systemic RNAi therapeutic 66 VIVITROL ® 66 BYETTA ® 66 platinum chemotherapeutic 66 Obatoclax 66 Xcytrin R 66 lamotrigine Lamictal 66 anti EGFR antibody 66 gastro intestinal inflammation 66 hyaluronidase enzyme 66 Avanafil 66 TransVax tm 66 Minocycline 66 Is Well Tolerated 66 midstage clinical 66 Cellcept 66 investigational monoclonal antibody 66 Epilepsy Drug 66 Hydrochloride Injection 66 synthetic siRNA